Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] price surged by 29.35 percent to reach at $0.23.
A sum of 54696251 shares traded at recent session while its average daily volume was at 2.19M shares. Biodexa Pharmaceuticals Plc ADR shares reached a high of $1.29 and dropped to a low of $0.9003 until finishing in the latest session at $1.03.
The one-year BDRX stock forecast points to a potential upside of 94.28. The average equity rating for BDRX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Biodexa Pharmaceuticals Plc ADR [BDRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BDRX shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BDRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Biodexa Pharmaceuticals Plc ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 08, 2024.
The Average True Range (ATR) for Biodexa Pharmaceuticals Plc ADR is set at 0.14 The Price to Book ratio for the last quarter was 2.32, with the Price to Cash per share for the same quarter was set at 3.12.
BDRX Stock Performance Analysis:
Biodexa Pharmaceuticals Plc ADR [BDRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.85. With this latest performance, BDRX shares dropped by -20.16% in over the last four-week period, additionally sinking by -75.48% over the last 6 months – not to mention a drop of -95.80% in the past year of trading.
Insight into Biodexa Pharmaceuticals Plc ADR Fundamentals:
Return on Equity for this stock declined to -45.75%, with Return on Assets sitting at -45.75%.
Biodexa Pharmaceuticals Plc ADR [BDRX] Institutonal Ownership Details
There are presently around $7.70%, or 7.79%% of BDRX stock, in the hands of institutional investors.
